dr. gulley on take home message with olaparib plus durvalumab in mcrpc
Published 6 years ago • 82 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
2:10
dr. gulley discusses a phase ii study of olaparib and durvalumab in mcrpc
-
1:14
dr. yu on combining pembrolizumab and olaparib in mcrpc
-
1:22
dr. pusztai on rationale for the i-spy 2 trial with durvalumab/olaparib combo in her2- breast cancer
-
1:18
dr. kibel on take-home messages in field of genitourinary cancers
-
1:08
dr. james l. gulley on atezolizumab, pembrolizumab, and avelumab's potential uses in bladder cancer
-
1:30
dr. james l. gulley on treatment beyond the second line in bladder cancer
-
9:02
chemotherapy for brca-mutated prostate cancer
-
8:33
adcs & checkpoint inhibitor combinations in tnbc
-
1:10
meet surgical oncologist craig slingluff, md
-
2:33
why bill calls my health record his life preserver
-
1:25
robert l. coleman, md, facog, facs, on how veliparib factors into ovarian cancer treatment
-
2:02
we are wellmed: dr. steven argumedo
-
2:55
your life matters!
-
2:07
controlling your bladder with dr. peter l rosenblatt
-
2:27
meet dr. sylvia ertel - ob/gyn care
-
1:49
gallbladder treatment improves thanks to technology
-
1:16
curing the whole family
-
3:00
biomarker-directed biscay data: durvalumab plus targeted therapies in muc
-
40:21
doc talk - women's health